MIT Researchers Automate Drug Design With Machine Learning

Artist's conception of drug design.

Researchers at the Massachusetts Institute of Technology are using machine learning to automate the process of developing and improving drugs.

Credit: University of Maryland School of Pharmacy

Massachusetts Institute of Technology (MIT) researchers are using machine learning to automate the process of developing and improving drugs.

The team trained a machine learning model on 250,000 molecular graphs, detailed images of a molecule’s structure. The model generated molecules, found the best base molecules from which to build, and designed new molecules with better properties.

The researchers found the model was able to complete these tasks more effectively than other systems designed to automate the drug design process.

In addition, the model was asked to modify 800 molecules to improve them for certain properties while keeping them similar in structure to the lead molecule. About 80% of the time, the system created new, similarly structured molecules that scored higher for those properties than did the original molecules.

From Engadget
View Full Article

 

Abstracts Copyright © 2018 Information Inc., Bethesda, Maryland, USA


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s